Universal reference book for medicines
Name of the drug: DEPANTOL ® (DEPANTHOL)

Active substance: chlorhexidine, dexpanthenol

Type: A drug that improves tissue regeneration with an antimicrobial effect for topical application in gynecology

Manufacturer: NIZHFARM (Russia)
Composition, form of production and packaging
?
Suppositories vaginal white or white with a grayish or yellowish hue of color, torpedo-shaped with a funnel-like depression; allowed marbling.
1 supp.

dexpanthenol 100 mg

chlorhexidine bigluconate 16 mg

(in the form of a chlorhexidine bigluconate solution of 20% - 85.2 mg)

Excipients: macrogol mixture (macrogol 400 - 2%, macrogol 1500 - 98%) - 2814.8 mg.

5 pieces.
- packings of cellular contour (1) - packs cardboard.
5 pieces.
- packings cellular planimetric (2) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2013.

PHARMACHOLOGIC EFFECT

Combination drug for topical application in gynecology, providing regenerative, antimicrobial, metabolic action.

Chlorhexidine is active against Gram-positive and Gram-negative bacteria: Treponema pallidum, Chlamydia spp., Ureaplasma spp., Neisseria gonorrhoeae, Gardnerella vaginalis, Bacteroides fragilis, Escherichia coli, Staphylococcus spp., Streptococcus spp .;
yeast, dermatophytes, protozoa (Trichomonas vaginalis). Some strains of Pseudomonas spp., Proteus spp., Are also insensitive to chlorhexidine. resistant to acid-fast forms of bacteria, bacterial spores.
Dexpanthenol stimulates the regeneration of mucous membranes, normalizes cellular metabolism, accelerates mitosis and increases the strength of collagen fibers.

Depantol ® does not interfere with the functional activity of lactobacilli.
It retains activity (albeit somewhat reduced) in the presence of blood, pus.
PHARMACOKINETICS

Data on the pharmacokinetics of the drug are not available.

INDICATIONS

- acute and chronic vaginitis;

- Endo / exocervicitis (including complicated ectopic cervical uteri);

- true erosion of the cervix of a specific etiology (as part of complex therapy);

- to improve the regeneration of the mucous membrane of the vagina and cervix after destructive methods of treatment (including diathermocoagulation, cryodestruction, laser-construction), in the postoperative and postpartum periods.

DOSING MODE

Depantol ® is used intravaginally.
Before use, the suppository should be freed from the contoured package.
Introduce 1 suppository 2 times / day for 7-10 days.
If necessary, prolongation of the course of treatment up to 20 days is possible.
SIDE EFFECT

There may be allergic reactions, itching, burning (passing after the withdrawal of the drug).

CONTRAINDICATIONS

- Hypersensitivity to the components of the drug.

PREGNANCY AND LACTATION

The use of depantola during pregnancy and during lactation is permitted.

OVERDOSE

Data on drug overdose are not provided.

DRUG INTERACTION

Depantol® is incompatible with detergents containing an anionic group (including saponins, sodium lauryl sulfate, sodium carboxymethyl cellulose) and soaps if they are administered intravaginally.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored out of reach of children, dry, protected from light at a temperature of no higher than 20 ° C.
Shelf life - 2 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!